Immunophenotypic characterization of lymphocytic infiltration in canine melanocytic tumors / Caracterização imunofenotípica da infiltração linfocítica em tumores melanocíticos caninos
DOI:
https://doi.org/10.34117/bjdv8n7-223Keywords:
melanoma, melanoma, immunohistochemistry, immunohistochemistry, lymphocytic infiltrate tumor, lymphocytic infiltrate tumor, tumor microenvironment, tumor microenvironment, dog., dog.Abstract
Melanocytic tumors correspond to approximately for 4 to 7% of tumors in dogs and up to 7% of malignant tumours. Melanomas generally exhibit aggressive biological behavior. In humans, abundant tumor-infiltrating lymphocytes (TIL) can be considered a good prognostic factor. Research on TIL in canine melanomas is scarce, and to date, there are no studies to verify its association with established prognostic factors. Our study aimed to evaluate the lymphocyte population in canine melanocytic tumors using immunohistochemical markers, and to relate this to pre-established clinicopathological prognostic variables and cell proliferation index (Ki-67). An exploratory cross-sectional study was conducted with 21 cases in 19 dogs, of which 71.5% were melanotic melanomas, 19% were melanocytomas and 9.5% were amelanotic melanomas. Ki-67 expression was elevated in amelanotic melanomas, indicating aggressive tumor behavior. We detected lymphocytes T and B through CD3 and CD20 markers, respectively, and found that 86.7% of the melanotic melanomas were positive for CD3, whereas 73.3% were negative for CD20. TIL showed a strong association with malignant tumors, as well as a correlation with other pre-established prognostic factors, such as necrosis, ulceration, and nuclear atypia. TIL need to be further investigated to verify its inclusion as a prognostic factor for canine melanomas.
References
ANSELMI JÚNIOR R, JUNG J, MORESCHI NETO V, LARSEN KSK, GENNARO L, LEME FEG, AZEVEDO MV, NORONHA LD. Avaliação imunofenotípica das subpopulações de linfócitos no infiltrado linfocitário tumoral em melanomas. Rev Soc Bras Clín Méd, 10, 2012.
ATHERTON MJ, MORRIS JS, MCDERMOTT MR, LICHTY BD. Cancer immunology and canine malignant melanoma: A comparative review. Vet Immunol Immunopathol, 169, 15–26, 2016.
AZIMI F, SCOLYER RA, RUMCHEVA P, MONCRIEFF M, MURALI R, Mc CARTHY SW, SAW RP, THOMPSON JF. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol, 30, 2678–83, 2012.
BARRA MB. O uso da imunoistoquímica no diagnóstico: indicações e limitações. Rev AMRIGS, 50, 173–84, 2006
BERGIN I, SMEDLEY R, ESPLIN D, SPANGLER W, KIUPEL M. Prognostic evaluation of Ki67 threshold value in canine oral melanoma. Vet Pathol, 48, 41–53, 2011.
BERGMAN PJ. Canine oral melanoma. Clin Tech Small Anim Pract, 22, 55–60, 2007.
BERNSEN MR, DIEPSTRA JHS, VAN MIL P, PUNT CJ, FIGDOR CG, VAN MUIJEN GN, ADEMA GJ, RUITER DJ. Presence and localization of T-cell subsets in relation to melanocyte differentiation antigen expression and tumour regression as assessed by immunohistochemistry and molecular analysis of microdissected T cells. J Pathol 202, 70–79, 2004.
BOSTOCK D. Prognosis after surgical excision of canine melanomas. Vet Pathol, 16, 32–40, 1979.
BURTON AL, et al. Prognostic significance of tumor infiltrating lymphocytes in melanoma. Am Surg, 77, 188-92, 2011.
BUSAM K, JUNGBLUTH A. Melan-A, a new melanocytic differentiation marker. Adv Anat Pathol, 6, 12–18, 1999.
CAMARGO LP, CONCEIÇÃO LG, DOS SANTOS COSTA PR. Neoplasias melanocíticas cutâneas em cães: estudo retrospectivo de 68 casos (1996-2004). Braz J Vet Res Anim Sci, 45, 138–52, 2008.
CAMPAGNE C, JULÉ S, ALLEAUME C, BERNEX F, EZAGAL J, ET AL. Canine melanoma diagnosis: RACK1 as a potential biological marker. Vet Pathol, 50, 1083–90, 2013.
CARVALHO MI, PIRES I, PRADA J, QUEIROGA FL. T-lymphocytic infiltrate in canine mammary tumours: clinic and prognostic implications. In Vivo, 25, 963–69, 2011.
CHEN Y-T, STOCKERT E, JUNGBLUTH A, TSANG S, COPLAN KA, SCANLAN MJ, OLD LJ. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc Nati Acad Sci, 93, 5915-19, 1996.
CHOI C, KUSEWITT D. Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas. Vet Pathol, 40, 713-18, 2003.
CLARK WH, ELDER DE, GUERRY D, BRAITMAN LE, TROCK BJ, SCHULTZ D, SYNNESTVEDT M, HALPEM AC. Model predicting survival in stage I melanoma based on tumor progression. J Nati Cancer Inst, 81, 1893–904, 1998.
CLEMENTE CG, MIHM MC, BUFALINO R, ZURRIDA S, COLLINI P, CASCINELLI N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer, 77, 1303–10, 1996.
COCKERELL G, SLAUSON D. Patterns of lymphoid infiltrate in the canine cutaneous histiocytoma. J Comp Pathol, 89, 193–203, 1979.
COTCHIN E. Melanotic tumours of dogs. J Comp Pathol Ther, 65, 115–29, 1955.
CURIEL TJ, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med, 10, 942, 2004.
DE VRIES TJ, FOURKOUR A, WOBBES T, VERKROOST G, RUITER DJ, VAN MUIJEN GN. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res, 57, 3223–29, 1997.
DIEFENBACH A, RAULET DH. 2002. The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev, 188, 9–21, 2002.
GILLARD M, et al. Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas. Pigm Cell Melanoma R, 27, 90–102, 2014.
GIUDICE C, CECILIANI F, RONDENA M, STEFANELLO D, GRIECO V. 2010. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A. J Vet Diagn Investig, 22, 389–94.
GOLDSCHMIDT MH, GOLDSCHMIDT KH. 2017. Epithelial and Melanocytic Tumors of the Skin. In:.Tumors in Domestic Animals, pp. 88–141.5rd Edit. Iowa State: Meuten DJ Eds., Ames, Wiley-Blackwell, 2017.
GOODEN MJ, DE BOCK GH, LEFFERS N, DAEMEN T, NIJMAN HW. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer, 105, 93–103, 2011.
HAHN K, DeNICOLA D, RICHARDSON R, HAHN E. Canine oral malignant melanoma: prognostic utility of an alternative staging system. J Small Anim Pract, 35, 251–56, 1994.
HORIUCHI Y, TOMINAGA M, ICHIKAWA M, YAMASHITA M, OKANO K, JIKUMARU Y, NARIAI Y, NAKAJIMA Y, KUWABARA M, YUKAWA M. Relationship between regulatory and type 1 T cells in dogs with oral malignant melanoma. Microbiol Immunol, 54, 152–59, 2010.
IUSSICH S, MANISCALCO L, DI SCIUVA A, IOTTI B, MORELLO E, MARTANO M, GATTINO F, BURACCO P, DE MARIA R. PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis. Vet Comp Oncol, 15, 462–69, 2016.
KIM JH, YU CH, YHEE JY, IM KS, SUR JH. Lymphocyte infiltration, expression of interleukin (IL)-1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours. J Comp Pathol, 142, 177–86, 2010.
KOENIG A, WOJCIESZYN J, WEEKS B, MODIANO J. Expression of S100a, vimentin, NSE, and Melan A/MART-1 in seven canine melanoma cell lines and twenty-nine retrospective cases of canine melanoma. Vet Pathol, 38, 427–35, 2001.
LACROUX C, RAYMOND-LETRON I, BOURGES-ABELLA N, LUCAS M, DEVIERS A, SERRA F, DEGORCE-RUBIALES F, DELVERDIER M. Study of canine cutaneous melanocytic tumours: Evaluation of histological and immunohistochemical prognostic criteria in 65 cases. Revue Méd Vét, 163, 393, 2012.
LAPRIE C, ABADIE J, AMARDEILH MF, NET JL, LAGADIC M, BELVERDIER M. MIB-1 immunoreactivity correlates with biologic behaviour in canine cutaneous melanoma. Vet Dermatol, 12, 139–47, 2001.
LIU W, BENNETT M, HELM T. Canine melanoma: a comparison with human pigmented epithelioid melanocytoma. Int J Dermatol, 50, 1542–45, 2011.
MADEJ, J. et al. An immunohistochemical analysis of lymphocytic infiltrations in canine skin cancers. Polish Journal of Veterinary Sciences, 20, 1, 141-147, 2017.
MARSIGLIANTE S, BISCOZZO L, MARRA A, NICOLARDI G, LEO G, LOBREGLIO GB, STORELLI C. Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens. Cancer Lett, 139, 33–41, 1999.
MARTÍNEZ C, PEÑAFIEL-VERDÚ C, VILAFRANCA M, RAMÍREZ G, MÉNDEZ-GALLEGO M, BUENDIA AJ, SÁNCHEZ J. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms. Vet Pathol, 48, 1204–11, 2011.
MILLANTA F, FRATINI F, CORAZZA M, CASTAGNARO M, ZAPPULLI V, POLI A. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour. Res Vet Sci, 73, 45–51, 2002.
MUKARATIRWA S. Prognostic and predictive markers in canine tumours: rationale and relevance. A review. Vet Q, 27, 52–64, 2005.
MUNDAY JS, LÖHR CV, KIUPEL M. Tumors of the alimentary tract In: Tumors in domestic animals, 4rd Edit., Meuten DJ, Eds.. Ames, Wiley Blackwell Iowa, pp. 515–23, 2017.
OBLE DA, LOEWE R, YU P, MIHM MC. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun, 9, 3, 2009.
OHSIE SJ, SARANTOPOULOS GP, COCHRAN AJ, BINDER SW. Immunohistochemical characteristics of melanoma. J Cutan Pathol, 35, 433–44, 2008.
PIRAS F, COLOMBARI R, MINERBA L, MURTAS D, FLORIS C, MAXIA C, CORBU A, PERRA MT, SIRIGU P. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase. Cancer, 104, 1246–54, 2005.
PIRES I, RODRIGUES P, ALVES A, QUEIROGA FL, SILVA F, LOPES C.. Immunohistochemical and immunoelectron study of major histocompatibility complex class-II antigen in canine cutaneous histiocytoma: its relation to tumor regression. In Vivo, 27, 257–62, 2013.
RAMOS-VARA JA, BEISSENHERZ ME, MILLER MA, JOHNSON GC, PACE LW, FARD A, KOTTLER SJ. Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases. Vet Pathol, 37, 597–608, 2000.
RODRÍGUEZ-PINTO D. B cells as antigen presenting cells. Cell Immunol, 238, 67–75, 2005.
ROELS S, TILMANT K, DUCATELLE R. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs. J Comp Pathol, 121, 13–24, 1999.
ROLIM VM, CASAGRANDE RA, WATANABE TT, WOUTERS AT, WOUTERS F, SONNE L, DRIEMEIER D. 2012. Amelanotic melanoma in dogs: a retrospective study of 35 cases (2004-2010) and immunohistochemical characterization. Pesq Vet Bras, 32, 340–46.
SCASE TJ, EDWARDS D, MILLER J, HENLEY W, SMITH K, BLUNDEN A, MURPHY S. Canine mast cell tumors: correlation of apoptosis and proliferation markers with prognosis. J Vet Intern Med, 20, 151–58, 2006.
SCHOLZEN T, GERDES J.. The Ki-67 protein: from the known and the unknown. J Cell Physiol, 182, 311–22, 2000.
SCHULTHEISS PC. Histologic features and clinical outcomes of melanomas of lip, haired skin, and nail bed locations of dogs. J Vet Diagn Invest, 18, 422–25, 2006.
SHEN M, SUN Q, WANG J, PAN W, REN X. Positive and negative functions of B lymphocytes in tumors. Oncotarget, 7, 34, 55828-55839, 2016.
SIMPSON RM, et al. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell Melanoma Res, 27, 37–47, 2014.
SINHA P, CLEMENTS VK, BUNT SK, ALBELDA SM, OSTRAND-ROSENBERG S. Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol, 179, 977–83, 2007.
SMEDLEY R, SPANGLER W, ESPLIN D, KITCHELL B, BERGMAN P, HO HY, BERGIN IL, KIUPEL M. Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation. Vet Pathol, 48, 54–72, 2011.
SMITH S, GOLDSCHMIDT M, MCMANUS P. A comparative review of melanocytic neoplasms. Vet Pathol, 39, 651–78, 2002.
SOMASUNDARAM R, et al. Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-β. Cancer Res, 62, 5267–72, 2002.
SPANGLER W, KASS P. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet Pathol, 43, 136–49, 2006.
SULAIMON S, KITCHELL B, EHRHART E. Immunohistochemical detection of melanoma-specific antigens in spontaneous canine melanoma. J Comp Pathol, 127, 162–68, 2002.
SULAIMON SS, KITCHELL BE. The basic biology of malignant melanoma: molecular mechanisms of disease progression and comparative aspects. J Vet Intern Med, 17, 760–72, 2003.
TAYLOR RC, PATEL A, PANAGEAS KS, BUSAM KJ, BRADY MS. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol, 25,869-75, 2007.
THOMAS NE, ET AL. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study. J Clin Oncol, 31, 4252–59, 2013.
TOMINAGA M, HORIUCHI Y, ICHIKAWA M, YAMASHITA M, OKANO K, JIKUMARU Y, NARIAI Y, KADOSAWA T. Flow cytometric analysis of peripheral blood and tumor-infiltrating regulatory T cells in dogs with oral malignant melanoma. J Vet Diagn Invest, 22, 438–41, 2010.
VASCELLARI M, GIANTIN M, CAPELLO K, CARMINATO A, MORELLO E, VERCELLI A, GRANATO A, BURACCO P, DACASTO M, MUTINELLI F. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis. Vet Pathol, 50, 110–21, 2013.
WATT V, RONCHESE F, RITCHIE D. Resting B cells suppress tumor immunity via an MHC class-II dependent mechanism. J Immunother, 30, 323–32, 2007.
WEBSTER J, YUZBASIYAN-GURKAN V, MILLER R, KANEENE J, KIUPEL M. Cellular proliferation in canine cutaneous mast cell tumors: associations with c-KIT and its role in prognostication. Vet Pathol, 44, 298–308, 2007.
YAZDI AS, MORSTEDT K, PUCHTA U, GHORESCHI K, FLAIG MJ, ROCKEN M, SANDES CA. Heterogeneity of T-cell clones infiltrating primary malignant melanomas. J Invest Dermatol, 126, 393–98, 2006.
YU P, FU Y-X. Tumor-infiltrating T lymphocytes: friends or foes?. Lab Invest, 86, 231, 2006.
